Dual antiplatelet therapy in patients with acute coronary syndrome during the coronavirus disease of 2019 pandemia: the right choice at the right time

J Cardiovasc Med (Hagerstown). 2020 Aug;21(8):535-537. doi: 10.2459/JCM.0000000000001028.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / drug therapy
  • Humans
  • Pandemics*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pneumonia, Viral*
  • Prasugrel Hydrochloride / therapeutic use*
  • SARS-CoV-2

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride